GTCR has announced a structured minority investment of up to $200 million in Solmetex, a prominent provider of dental products and systems. The investment, which was both signed and closed simultaneously, is designed to accelerate Solmetex’s growth strategy and support near-term add-on acquisitions.
Solmetex, founded in 1994, began as a dental water treatment company focused on mercury waste removal from dental offices. Today, the company serves over 85,000 dental offices across the United States, offering a range of products that include amalgam separation, waterline safety solutions, dental isolation technology, and regenerative biomaterials. Over the years, Solmetex has expanded its product portfolio through strategic acquisitions and integration of complementary technologies, positioning itself as a comprehensive provider of dental practice solutions.
GTCR will partner with existing shareholders, including AGIC Capital, an international private equity firm with expertise in healthcare and industrial technology investments across Europe, Asia, and the United States. Together, GTCR and AGIC aim to further scale Solmetex’s business through both organic expansion and strategic acquisitions.
The investment will provide Solmetex with additional resources to strengthen its position in the dental market and pursue high-impact growth opportunities. Solmetex CEO Gene Dorff and his leadership team will continue to oversee operations and lead the company’s strategic direction.
GTCR emphasized that its collaboration with Solmetex is part of its broader strategy of backing market-leading companies in healthcare and other key sectors. The firm, founded in 1980, has invested more than $30 billion in over 300 companies, employing its “Leaders Strategy” approach to build industry-leading businesses through organic growth and acquisitions. GTCR currently manages about $50 billion in equity capital.
AGIC Capital, which manages approximately $2.2 billion in assets, will continue to support Solmetex through its industry expertise and global investment reach.
KEY QUOTES:
“We are excited to support Solmetex’s next phase of growth. Solmetex is a high-quality business that is uniquely situated in the dental supply chain, and we look forward to leveraging our team’s investment expertise across the U.S. healthcare ecosystem to build upon its strong foundation.”
Luke Marker, Managing Director, GTCR
“We are pleased to partner with AGIC through this structured investment. Through flexible capital solutions and strategic insights, GTCR supports exceptional management teams in executing growth initiatives and driving value creation.”
Jason Prager, Managing Director, GTCR
